Price$32.94+0.34 (+1.04%)
12:00 PM07:45 PM
News · 26 weeks109+24%
2025-12-282026-06-21
Mix5990d
- Insider28(47%)
- Other18(31%)
- SEC Filings8(14%)
- Earnings2(3%)
- Analyst2(3%)
- Leadership1(2%)
Latest news
25 items- INSIDERChief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. covered exercise/tax liability with 15,396 shares and converted options into 32,919 shares, increasing direct ownership by 56% to 48,961 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERPAO Becklund Irene converted options into 15,971 shares, covered exercise/tax liability with 5,870 shares and sold $370,518 worth of shares (12,063 units at $30.72) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 6,790 units (SEC Form 4) (for tax liability)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 23,315 shares, increasing direct ownership by 6% to 318,314 units (SEC Form 4) to cover taxes4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Executive Officer Dudum Andrew covered exercise/tax liability with 85,632 shares and converted options into 154,991 shares, increasing direct ownership by 8% to 957,043 units (SEC Form 4) (withholding tax)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERCTO Elshenawy Mohamed converted options into 282,597 shares, covered exercise/tax liability with 151,534 shares and sold $946,260 worth of shares (30,040 units at $31.50) as part of a pre-agreed trading plan (SEC Form 4) (tax withholding)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Wells David B converted options into 4,613 shares, increasing direct ownership by 2% to 229,030 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Perez Garcia Andrea G converted options into 3,656 shares, increasing direct ownership by 5% to 83,822 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Schultz Kare converted options into 3,656 shares, increasing direct ownership by 23% to 19,397 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 4,091 shares, increasing direct ownership by 2% to 187,971 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. converted options into 3,656 shares, increasing direct ownership by 13% to 31,438 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 3 filed by new insider Amoo-Gottfried Kofi Owusu3 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Payne Christopher D converted options into 14,343 shares, increasing direct ownership by 72% to 34,318 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Pendarvis Christiane converted options into 3,656 shares, increasing direct ownership by 7% to 55,430 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Manuel Anja converted options into 13,696 shares, increasing direct ownership by 55% to 38,671 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Cosgrove Delos M. converted options into 3,656 shares, increasing direct ownership by 6% to 67,995 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- SECHims & Hers Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
- PRHims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of HimsAn expert in longevity medicine and preventive healthcare, Vinjamoori joins Hims & Hers to help more men feel great at every stage of life Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health, as well as emerging categories like longevity medicine and peptide therapy. He joins a team of m
- SECHims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
- PRHims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for CanadiansBuilding on its Canadian launch and the historic introduction of generic semaglutide, Hims & Hers brings the full power of the world's largest consumer health platform — and Juniper's proven track record — to more Canadians than ever Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advan
- PRHims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in GermanyClosing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, advancing its position as the world's largest consumer health platform. In Germany, the closing strengthens Juniper's comprehensive, clinically rigorous, weight management offering with the technology, data, and infrastructure of Hims & Hers behind it. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602926942/en/Closing brings world-class technology and clinical infrastructu
- PRHims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health PlatformThe acquisition extends the company's leadership position across Australia, Canada, Germany, Japan, and the United Kingdom, with the scale to redefine healthcare for hundreds of millions of people Hims & Hers Health, Inc. (NYSE:HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on the earlier acquisitions of ZAVA and Livewell, Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France, Germany, Ireland, Spain, and Japan. Continuing to expand internationally will enable Hims & Hers to lead the next era of digital health, delivering personal, af
- PRHims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese MarketClosing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers' technology, data, and clinical infrastructure behind a platform that supports weight management care for people in Japan, a market the company approaches with deep respect for its distinct healthcare values and the trust people place in those who serve them. This press release features multimedia. View the full release here: https://www.businesswire.com/ne
HIMS FAQ
7 questionsWhat does Hims & Hers Health Inc. do?
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin...Where does HIMS stock trade?
Hims & Hers Health Inc. (HIMS) is listed on NYSE.What sector and industry is HIMS in?
Hims & Hers Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did Hims & Hers Health Inc. go public?
Hims & Hers Health Inc. (HIMS) completed its IPO in 2019.What are analysts saying about HIMS?
Hims & Hers Health Inc. has had 8 recent analyst actions on file. The most recent action was from Needham: Buy with a $3500.00 price target on 2026-05-12. Recent price targets range from $2300.00 to $4800.00.What companies are similar to HIMS?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), AMED (Amedisys Inc), LHCG (LHC Group), LFST (LifeStance Health Group Inc.). Compare HIMS side-by-side with any of them on Quantisnow.How can I track HIMS on Quantisnow?
Quantisnow aggregates Hims & Hers Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HIMS to receive live email and push alerts on every new disclosure.